Fruquintinib Side Effects
Medically reviewed by Drugs.com. Last updated on Jan 15, 2024.
Applies to fruquintinib: oral capsule.
Serious side effects of Fruquintinib
Along with its needed effects, fruquintinib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking fruquintinib:
More common
- Bleeding gums
- blurred vision
- cloudy urine
- constipation
- coughing up blood
- depressed mood
- dizziness
- dry skin and hair
- feeling cold
- hair loss
- headache
- hoarseness or husky voice
- increased menstrual flow or vaginal bleeding
- muscle cramps and stiffness
- nervousness
- nosebleeds
- paralysis
- pounding in the ears
- prolonged bleeding from cuts
- red or black, tarry stools
- red or dark brown urine
- redness, swelling, or pain of the skin
- scaling of the skin on the hands and feet
- slow or fast heartbeat
- tingling of the hands and feet
- trouble breathing
- ulceration of the skin
- unusual tiredness or weakness
- weight gain
Less common
- Bladder pain
- bloody or cloudy urine
- body aches or pain
- chest pain or tightness
- cough
- difficult, burning, or painful urination
- ear congestion
- fever or chills
- frequent urge to urinate
- heartburn
- indigestion
- lower back or side pain
- loss of voice
- severe stomach pain, cramping, or burning
- sneezing
- sore throat
- stuffy or runny nose
- vomiting of blood or material that looks like coffee grounds
Rare
- Agitation
- back pain
- coma
- confusion
- drowsiness
- hallucinations
- irritability
- mood or mental changes
- seizures
- stiff neck
- sudden weakness in the arms or legs
Incidence not known
- Dark urine
- loss of appetite
- nausea or vomiting
- pains in the chest, groin, or legs, especially calves of the legs
- sudden loss of coordination
- sudden onset of slurred speech
- sudden vision changes
- yellow eyes or skin
Other side effects of Fruquintinib
Some side effects of fruquintinib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Diarrhea
- difficulty in moving
- joint pain
- muscle or bone pain
- swelling or inflammation of the mouth
- throat pain
- weight loss
Less common
- Pain in the rectum
For Healthcare Professionals
Applies to fruquintinib: oral capsule.
General
The most common adverse reactions that occurred in 20% or more patients were hypertension, palmar-plantar erythrodysesthesia (PPE), proteinuria, dysphonia, abdominal pain, diarrhea, and asthenia.[Ref]
Cardiovascular
Very common (10% or more): Hypertension (up to 61%), hemorrhage (up to 28%)
Uncommon (0.1% to 1%): Arterial thromboembolic event[Ref]
Dermatologic
Very common (10% or more): PPE (up to 49%)
Common (1% to 10%): Rash[Ref]
Endocrine
Very common (10% or more): Hypothyroidism (up to 21%)[Ref]
Gastrointestinal
Very common (10% or more): Stomatitis (up to 33%), abdominal pain (up to 29%), diarrhea (up to 25%)
Common (1% to 10%): Proctalgia, gastrointestinal hemorrhage, gastrointestinal perforation or fistula, intestinal obstruction
Frequency not reported: Vomiting[Ref]
Hematologic
Very common (10% or more): Decreased lymphocytes (up to 30%), decreased platelets (up to 30%), increased activated partial thromboplastin time (up to 21%), decreased hemoglobin (up to 23%)
Uncommon (0.1% to 1%): Thrombotic microangiopathy[Ref]
Hepatic
Very common (10% or more): Increased AST (up to 42%), increased ALT (up to 34%)
Frequency not reported: Hepatic function abnormalities, hepatic failure/encephalopathy[Ref]
Metabolic
Very common (10% or more): Anorexia (up to 21%), increased glucose (up to 43%), increased urate (up to 26%)[Ref]
Musculoskeletal
Very common (10% or more): Musculoskeletal pain (up to 22%), back pain (up to 15%) arthralgia (up to 13%)[Ref]
Nervous system
Uncommon (0.1% to 1%): Posterior reversible encephalopathy syndrome
Frequency not reported: Cerebral infarction[Ref]
Other
Very common (10% or more): Fatigue (up to 53%), increased triglycerides (53%), increased cholesterol (37%), decreased albumin (up to 35%), decreased sodium (up to 35%), increased alkaline phosphatase (up to 40%), decreased magnesium (up to 20%), decreased calcium (up to 25%), decreased potassium (up to 22%)
Uncommon (0.1% to 1%): Sepsis, septic shock
Frequency not reported: Multiple organ dysfunction, bacterial infection, asthenia, wound dehiscence[Ref]
Renal
Very common (10% or more): Proteinuria (up to 55%), increased creatinine (up to 87%)
Common (1% to 10%): Urinary tract infection, pneumonia[Ref]
Respiratory
Very common (10% or more): Dysphonia (up to 38%), throat pain (up to 10%)
Common (1% to 10%): Epistaxis, upper respiratory tract infection
Frequency not reported: Hemoptysis, lower respiratory infection[Ref]
More about fruquintinib
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
References
1. Product Information. Fruzaqla (fruquintinib). Takeda Pharmaceuticals America. 2023.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.